BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22320957)

  • 1. Overexpression of Snail accelerates adriamycin induction of multidrug resistance in breast cancer cells.
    Li W; Liu C; Tang Y; Li H; Zhou F; Lv S
    Asian Pac J Cancer Prev; 2011; 12(10):2575-80. PubMed ID: 22320957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
    Tsou SH; Chen TM; Hsiao HT; Chen YH
    PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein.
    Chen WJ; Wang H; Tang Y; Liu CL; Li HL; Li WT
    Chin J Cancer; 2010 Feb; 29(2):151-7. PubMed ID: 20109342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
    J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity.
    Mezencev R; Matyunina LV; Jabbari N; McDonald JF
    BMC Cancer; 2016 Mar; 16():236. PubMed ID: 26988558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
    Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snail-Induced Epithelial-to-Mesenchymal Transition Enhances P-gp-Mediated Multidrug Resistance in HCC827 Cells.
    Tomono T; Yano K; Ogihara T
    J Pharm Sci; 2017 Sep; 106(9):2642-2649. PubMed ID: 28322937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
    Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells.
    Tsou SH; Hou MH; Hsu LC; Chen TM; Chen YH
    Int J Mol Med; 2016 Jan; 37(1):233-42. PubMed ID: 26572087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro.
    Gao A; Liang H; Wang X; Zhang X; Jing M; Zhang J; Yan Y; Xiang W
    Eur J Pharmacol; 2011 Jun; 659(2-3):108-13. PubMed ID: 21458446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
    Dönmez Y; Gündüz U
    Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Snail and E-cadherin in Drug-resistant MCF-7/ADM Breast Cancer Cell Strains.
    Cai F; Xiao H; Sun Y; Wang D; Tang J
    J Coll Physicians Surg Pak; 2019 Mar; 29(3):240-244. PubMed ID: 30823950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
    Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
    Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells.
    Zhang W; Feng M; Zheng G; Chen Y; Wang X; Pen B; Yin J; Yu Y; He Z
    Biochem Biophys Res Commun; 2012 Jan; 417(2):679-85. PubMed ID: 22166209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of LY294002 on adriamycin-induced epithelial-mesenchymal transition in human breast carcinoma cells.
    Qian YJ; Cheng XM; Wang B; Xu L; Wu CJ; Zhao ML; Qi XH; Guo J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug; 34(4):319-23. PubMed ID: 22954111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
    Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y
    J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
    Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
    Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor β signaling in HCT116 colon cancer cells.
    Li J; Liu H; Yu J; Yu H
    Mol Med Rep; 2015 Jul; 12(1):192-8. PubMed ID: 25684678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistant breast cancer cells overexpress ETS1 gene.
    Kars MD; Işeri OD; Gündüz U
    Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.